This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marwick, T. H. Articles by Thomas, J. D. Search for Related Content PubMed PubMed Citation Articles by Marwick, T. H. Articles by Thomas, J. D.

A clinical and echocardiographic score for assigning risk of major events after dobutamine echocardiograms

Thomas H. Marwick, MBBS, PhD^*,*, Colin Case, MS^*, Don Poldermans, MD, Eric Boersma, PhD, Jeroen Bax, MD, Stephen Sawada, MD and James D. Thomas, MD, FACC

^* Department of Medicine, University of Queensland, Brisbane, Australia
Thoraxcenter, Rotterdam, Netherlands
Indiana University Hospital, Indianapolis, Indiana, USA
Cleveland Clinic Foundation, Cleveland, Ohio, USA

View larger version (23K): [in a new window]   Figure 1 Distribution of patients and events into the modeling and internal validation groups for dobutamine echocardiography. MI = myocardial infarction.

View larger version (12K): [in a new window]   Figure 3 Outcomes of high-, intermediate-, and low-risk groups in the external validation group undergoing dobutamine echocardiography.

View larger version (20K): [in a new window]   Figure 2 Outcomes of high-, intermediate-, and low-risk groups in the modeling (A) and internal validation (B) groups undergoing dobutamine echocardiography.